Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Penn Medicine Lancaster General Health's Ambulatory Care Evolution.

Frontiers of health services management·2021
Same journal

'The little things count': delivering dignified care.

Nursing times·2018
Same journal

The heart of the hospital.

Nursing times·2018
Same journal

The nurse's role in caring for people with dementia.

Nursing times·2018
Same journal

Hepatitis C and the ongoing challenge of genotype 3.

Nursing times·2018
Same journal

Implementing change in older people's acute care.

Nursing times·2018
Same journal

A total health economy approach to revalidation.

Nursing times·2018
See all related articles

Related Experiment Video

Updated: May 19, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Managing C difficile relapses in the community.

Susan Wynne1

  • 1Halton and St. Helens Division, Bridgewater Community Healthcare Trust.

Nursing Times
|August 7, 2012
PubMed
Summary
This summary is machine-generated.

Nurses face challenges managing recurrent Clostridioides difficile infections in the community. A new clinical pathway was developed to support older patients and their families through these difficult episodes.

More Related Videos

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Related Experiment Videos

Last Updated: May 19, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Area of Science:

  • Infectious Diseases
  • Geriatric Care
  • Nursing Practice

Background:

  • Recurrent Clostridioides difficile infections (CDI) pose significant challenges for community-dwelling older adults.
  • Existing care models may not adequately address the complex needs of patients with repeated CDI episodes and their families.
  • Nurses require specific tools and pathways to effectively manage these patients in non-acute settings.

Purpose of the Study:

  • To report the development of a clinical pathway designed for the community management of recurrent Clostridioides difficile.
  • To address the unmet needs of older patients experiencing multiple CDI episodes.
  • To provide a structured approach for nurses caring for this patient population.

Main Methods:

  • A multidisciplinary team was convened to review current literature and best practices.
  • Key components of care were identified, including patient education, symptom monitoring, and caregiver support.
  • The pathway was designed iteratively, incorporating feedback from clinical experts and potential users.

Main Results:

  • A comprehensive clinical pathway was developed, outlining key interventions and care transitions.
  • The pathway emphasizes patient and family engagement, self-management support, and timely access to resources.
  • It provides a framework for consistent and evidence-based care delivery in the community setting.

Conclusions:

  • The developed clinical pathway offers a structured approach to managing recurrent Clostridioides difficile in older adults within the community.
  • This pathway aims to improve patient outcomes, enhance family support, and optimize nursing care delivery.
  • Further research should evaluate the pathway's effectiveness and impact on patient quality of life and healthcare utilization.